Sharon Rosenzweig‐Lipson

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

Robert H. Ring, Jessica E. Malberg, Lisa Potestio et al. · Psychopharmacology · 2006 · 320 citations

Autonomic Evidence, Anxiolytic-like Activity, Behavioral Neuroscience +12

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes

Stacey J. Sukoff Rizzo, Sarah J. Neal Webb, Zoë A. Hughes et al. · Translational Psychiatry · 2012 · 232 citations · Full text

Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466

Lee E. Schechter, Qian Lin, Deborah L. Smith et al. · Neuropsychopharmacology · 2007 · 217 citations · Full text

Neuropharmacological Profile, Functional Selectivity, Medicine +9

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

Darrick T. Balu, Brian A. Hoshaw, Jessica E. Malberg et al. · Brain Research · 2008 · 193 citations · Full text

Psychiatry, Medicine, Psychotropic Medication +11

ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

Feng Liu, Steve Grauer, Cody Kelley et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 181 citations